Results
1 -
10 of
29
(Click
here to explore results)
- Design, synthesis and in silico screening of benzoxazole–thiazolidinone hybrids as potential inhibitors of SARS-CoV-2 proteases. Vijay Sai Krishna Cheerala, Prasanth Ghanta, Sundaresan Chittor Neelakantan
, RSC Adv.
, 2021
, 11
, 39328
- Review on fluorinated nucleoside/non-nucleoside FDA-approved antiviral drugs. Magda M. F. Ismail, Mohammed Salah Ayoup
, RSC Adv.
, 2022
, 12
, 31032
- Rhodium-catalysed asymmetric hydrogenation as a valuable synthetic tool for the preparation of chiral drugs. Pablo Etayo, Anton Vidal-Ferran
, Chem. Soc. Rev.
, 2013
, 42
, 728
- Anti-HIV drug repurposing against SARS-CoV-2. Peng Sang, Shu-Hui Tian, Zhao-Hui Meng, Li-Quan Yang
, RSC Adv.
, 2020
, 10
, 15775
- Biocatalytic routes to anti-viral agents and their synthetic intermediates. Sjoerd Slagman, Wolf-Dieter Fessner
, Chem. Soc. Rev.
, 2021
, 50
, 1968
- Microwave-assisted synthesis of small molecules targeting the infectious diseases tuberculosis, HIV/AIDS, malaria and hepatitis C. Johan Gising, Luke R. Odell, Mats Larhed
, Org. Biomol. Chem.
, 2012
, 10
, 2713
- High-throughput screening for modulators of protein–protein interactions: use of photonic crystal biosensors and complementary technologies. James T. Heeres, Paul J. Hergenrother
, Chem. Soc. Rev.
, 2011
, 40
, 4398
- Computational analysis of macrolides as SARS-CoV-2 main protease inhibitors: a pattern recognition study based on molecular topology and validated by molecular docking. Riccardo Zanni, Maria Galvez-Llompart, Jorge Galvez
, New J. Chem.
, 2021
, 45
, 8654
- Glucuronides from metabolites to medicines: a survey of the in vivo generation, chemical synthesis and properties of glucuronides. Andrew V. Stachulski, Xiaoli Meng
, Nat. Prod. Rep.
, 2013
, 30
, 806
- Computational methods directed towards drug repurposing for COVID-19: advantages and limitations. Prem Prakash Sharma, Meenakshi Bansal, Aaftaab Sethi, Poonam, Lindomar Pena, Vijay Kumar Goel, Maria Grishina, Shubhra Chaturvedi, Dhruv Kumar, Brijesh Rathi
, RSC Adv.
, 2021
, 11
, 36181